Once in production, which could occur as early as July, the Dome Mountain mine is expected to output 15,000 oz. of gold per ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) ("Great Pacific Gold," "GPAC," or the "Company") is pleased ...

Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce high-grade […] ...

Japan Gold Corp. (TSXV: JG) (OTCQB: JGLDF) ("Japan Gold" or the "Company") is pleased to report the results of the initial ...

Lucy Letby's case is to be reviewed by the Criminal Cases Review Commission (CCRC), which investigates potential miscarriages ...

Three drill holes that tested the extensions of the Jubilee Shear at depth intersected quartz veins with visible gold approximately 170 m and 100 m away from the closest intersections, including in ...

Corporation (NASDAQ:NVNO), a medical device company with a market capitalization of $54.5 million, reported interim two-year follow-up data from its pivotal trial of the VenoValve, indicating ...

The plant immune system, which differs significantly from that of humans, utilises small RNA sequences to deactivate or ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

This edition of Bulls N’ Bears Big Hits examines some notable drill intercepts revealed on the ASX, including Tanami Gold’s Central Tanami project in the Northern Territory, which intersected 3.80m at ...

Equine surgeon Dr. Larry Bramlage says the type and length of turnout a horse gets when healing makes a crucial difference ...